NCT01505400unknownactive not recruiting

Integrated Molecular Profiling in Advanced Cancers Trial

University Health Network, Toronto · with Princess Margaret Hospital, Canada

ClinicalTrials.gov

3026

Enrollment · actual

Countries · 1 sites

2027-07

Primary completion

1 mo ago

Record updated

Commercial relevance

No explicit biomarker / molecular-testing language identified in the public record.

Change timeline

No changes detected yet. The first refresh records a baseline snapshot; subsequent refreshes generate field-level changes.

Signals from this trial

New trial
34/100
Opportunity
New unknown trial NCT01505400 posted by University Health Network, Toronto: "Integrated Molecular Profiling in Advanced Cancers Trial".
ClinicalTrials.gov record updated 56 days ago.

Eligibility — raw, for validation

Inclusion Criteria:

* Patients with histological confirmation of advanced breast, non-small cell lung, colorectal, genitourinary, pancreatobiliary gastrointestinal, upper aerodigestive tract, gynecological, melanoma, unknown primary, and rare carcinomas who are candidates for systemic therapy, as well as patients who are phase I trial candidates.
* Patient must be ≥ 18 years old.
* Patient's ECOG performance status equal to 0 or 1.
* All patients must have signed and dated an informed consent form.
* All patients must have sufficient archived tumor tissue for molecular profiling.

Exclusion Criteria:

* None